A First-in-Human Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Novel Anti-Interleukin 1 Biologic Agent, Rph-104, in Healthy Subjects

Gul, AhmetUlker, SibelSenturk, Recep SelimTurk, Ugur OnselGurgun, CemilLavrovsky, YanSamsonov, MikhailOzen, SebnemAltinel, Serdar2019-10-272019-10-2720172326-51912326-5205https://hdl.handle.net/11454/31618eninfo:eu-repo/semantics/closedAccessA First-in-Human Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Novel Anti-Interleukin 1 Biologic Agent, Rph-104, in Healthy SubjectsConference Object69WOS:000411824102080Q1